Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹500 | ₹1000 |
Expense Ratio | 0.91 | 2.21 |
NAV | ₹15.92 | ₹80.69 |
Fund Started | 14 Feb 2022 | 03 Jul 2008 |
Fund Size | ₹534.42 Cr | ₹1013.18 Cr |
Exit Load | - | Exit load of 1%, if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 2.08% | -6.78% |
3 Year | 16.32% | 13.49% |
5 Year | - | 25.01% |
1 Year
3 Year
5 Year
Equity | 100.29% | 99.32% |
Cash | -0.29% | -4.20% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Nestle India Ltd. | 3.84% |
ICICI Bank Ltd. | 3.80% |
Sun Pharmaceutical Industries Ltd. | 3.77% |
MRF Ltd. | 3.72% |
HDFC Bank Ltd. | 3.69% |
ITC Ltd. | 3.65% |
Hindustan Unilever Ltd. | 3.60% |
Dr. Reddy's Laboratories Ltd. | 3.57% |
Britannia Industries Ltd. | 3.52% |
Asian Paints Ltd. | 3.43% |
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.90% |
Grasim Industries Ltd. | 9.87% |
Larsen & Toubro Ltd. | 8.14% |
Life Insurance Corporation of India | 7.22% |
Coal India Ltd. | 6.15% |
NTPC Ltd. | 6.12% |
JIO Financial Services Ltd. | 5.69% |
Bajaj Finserv Ltd. | 4.83% |
Adani Enterprises Ltd. | 4.73% |
Aurobindo Pharma Ltd. | 4.18% |
Name | Sharwan Kumar Goyal | Ankit A Pande |
Start Date | 02 Jul 2018 | 22 Aug 2023 |
Name
Start Date
Description | The scheme seeks to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error. | The scheme seeks to provide capital appreciation by investing in a focused portfolio of Large cap -'bluechip' companies |
Launch Date | 14 Feb 2022 | 03 Jul 2008 |
Description
Launch Date